Saturday, October 26, 2019

Moderators: Stanley Leong and Merrick Ross                                                                   

8:30         Introduction                                                                                                             

8:35         KEYNOTE: Omid Hamid, MD, The Angeles Clinic & Research Institute, West Los Angeles, USA, IMMUNOTHERAPY OF CANCER IN THE ERA OF CHECKPOINT INHIBITORS

9:05         Jianda Yuan, MD, PhD, Merch Research Labs, Kenilworth, USA
CANCER NEOANTIGENS: POTENTIAL TARGETS FOR IMMUNOTHERAPY

9:25         Michael Nishimura, PhD, Loyola University Chicago Stritch School of Medicine, Chicago, USA
T CELL RECEPTOR TRANSDUCED T CELLS FOR THE IMMUNOTHERAPY OF CANCER

9:45         Q&A Panel Discussion